Credo insider plans $5.0M stock sale for 2026

Credo Technology Group Holding Ltd (CRDO) received a notice that William Joseph Brennan, through The Brennan Family Trust dated September 6, 2002, plans to sell common shares under Rule 144.

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd (CRDO) received a notice that William Joseph Brennan, through The Brennan Family Trust dated September 6, 2002, plans to sell common shares under Rule 144. A total of 33,338 common shares are planned to be sold through Goldman Sachs & Co. LLC, with an aggregate market value of $5,003,700.42, on or about September 14, 2026.

The shares were originally acquired from Credo in a private transaction on January 31, 2022. The planned sales are made under a selling plan dated June 10, 2026 that is intended to comply with Rule 10b5-1(c). Credo had 187,951,918 common shares outstanding at the time referenced in the notice.

Key Figures

Shares to be sold under Rule 144: 33,338 shares Aggregate market value of planned sale: $5,003,700.42 Credo common shares outstanding: 187,951,918 shares +3 more

6 metrics

Shares to be sold under Rule 144 33,338 shares Common shares planned to be sold for the account of William Joseph Brennan

Aggregate market value of planned sale $5,003,700.42 Market value of 33,338 Credo common shares to be sold

Credo common shares outstanding 187,951,918 shares Shares outstanding for Credo Technology Group Holding Ltd referenced in the notice

Date shares were acquired January 31, 2022 Acquired from issuer in a private transaction

Planned sale date September 14, 2026 Approximate date of sale for the Rule 144 transaction

Selling plan date June 10, 2026 Date of the selling plan intended to comply with Rule 10b5-1(c)

Key Terms

Rule 144, Rule 10b5-1(c), selling plan

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Rule 10b5-1(c) regulatory

"selling plan dated 6/10/2026, that is intended to comply with Rule 10b5-1(c)"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

selling plan financial

"sales of shares set forth herein are made in connection with a selling plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CRDO?

It discloses that 33,338 common shares of Credo Technology Group Holding Ltd are planned to be sold under Rule 144, with Goldman Sachs & Co. LLC acting as broker and an aggregate market value of $5,003,700.42.

Who is selling Credo (CRDO) shares in this Form 144?

The planned sale is for the account of William Joseph Brennan, with all shares to be sold from The Brennan Family Trust, DTD 09/06/2002. Goldman Sachs & Co. LLC signed the notice on his behalf as broker.

How many Credo (CRDO) shares and what value are covered by the Form 144?

The notice covers 33,338 common shares of Credo with an aggregate market value of $5,003,700.42, to be sold on or about September 14, 2026 on a national securities association (NASD) market.

When and how were the Credo (CRDO) shares being sold under Form 144 acquired?

The 33,338 common shares covered by the notice were acquired from the issuer in a private transaction on January 31, 2022, with the issuer listed as the person from whom they were acquired.

Is the Credo (CRDO) Form 144 sale under a Rule 10b5-1 plan?

Yes. The remarks state the sales are made in connection with a selling plan dated June 10, 2026, which is intended to comply with Rule 10b5-1(c), indicating a pre-arranged trading plan.

How many Credo (CRDO) shares were outstanding according to the Form 144?

The Form 144 states that Credo Technology Group Holding Ltd had 187,951,918 common shares outstanding at the time referenced in the securities information section of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:01 PM Accepted by SEC EDGAR 09/14/2026 - 06:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001896237
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Credo Technology Group Holding Ltd
SEC File Number	001-41249
Address of Issuer	Maples Corporate Services, Limited PO Box 309, Ugland House Grand Cayman CAYMAN ISLANDS KY1-1104
Phone	408-664-9329
Name of Person for Whose Account the Securities are To Be Sold	William Joseph Brennan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	33338	5003700.42	187951918	09/14/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	01/31/2022	Acquired from issuer in private transaction	Issuer			33338	01/31/2022	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 6/10/2026, that is intended to comply with Rule 10b5-1(c). All shares are to be sold from The Brennan Family Trust, DTD 09/06/2002.
Date of Notice	09/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of William Joseph Brennan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)